Strata Oncology Announces Personalized Recurrence Monitoring Trial
Study to Evaluate Strata's Ability to Detect Tumor Recurrence using Liquid Biopsy and Monitor Treatment Effectiveness for Patients with Early-Stage Solid Tumors ANN ARBOR, Mich., Jan. 13, 2021 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced plans to begin enrolling the Sentinel Trial in the first half of 2021. [...]